Dear NMA Members, Sponsors & Investors, join us to hear from Yun Li of Nob Hill Therapeutics.
Nob Hill Therapeutics mission is to commercialize the first of its kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.
The Platform technology is also be able to deliver drugs that treat lung cancer and other deadly lung diseases. The targeted delivery will minimize drug side effects/toxicities and provide high concentrations of drug to the site of disease/infection.
Zoom link will be provided upon registration. See you there!